Physician profile
Sigrid Blome Eberwein
NPI 1255348918
$110,754.93
in general payments reported to CMS, 2019-2025
16 companies · $43K in 2025
The $43K reported for 2025 was more than what 98% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $7,545 · 2021: $14K · 2022: $573 · 2023: $5,288 · 2024: $29K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $46K · Travel and Lodging: $15K · Honoraria: $7,250 · Food and Beverage: $3,896 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,635 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,800 · Education: $48.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $46,425.00 |
| Travel and Lodging | $14,674.73 |
| Honoraria | $7,250.00 |
| Food and Beverage | $3,895.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,635.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,800.00 |
| Education | $48.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $56,892.62 | 2023-2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $34,609.06 | 2019-2025 | Cohealyx, Recell, Permeaderm |
| Vericel Corporation | $6,241.55 | 2019-2024 | Nexobrid |
| Polarityte, INC. | $6,031.13 | 2019 | |
| Acera Surgical, INC. | $2,635.00 | 2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $1,119.92 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medline Industries Lp | $880.84 | 2019-2025 | |
| Access Pro Medical, LLC | $599.66 | 2023-2025 | Matriderm, Matriderm |
| Kci USA, INC. | $593.75 | 2019 | |
| Urgo Medical North America, LLC | $488.23 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Kerecis Limited | $457.76 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $146.03 | 2022-2025 | Collagenase Santyl |
| Polymedics Innovations INC. | $26.09 | 2025 | |
| Boston Scientific Corporation | $24.84 | 2019 | |
| Biocomposites INC | $8.45 | 2025 | Stimulan |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sigrid Blome Eberwein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.